Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 6.5 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., Celgene Corporation, Lilly, Merck Sharp & Dohme Corp., Sirtex Medical Inc., and Taiho Oncology.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Saturday, April 29, 2017
New York, NY Times Square
300 W 44th St, New York, NY 10036
There is a need for specialized education for clinicians who manage some of the most difficult-to-treat forms of gastrointestinal cancers. The School of Gastrointestinal Oncology™ (SOGO™) will provide a multi-track curriculum-based program focused exclusively on gastrointestinal tumors’ management. This intensive 1-day interactive program will provide a comprehensive review of data on the most important aspects related to the multidisciplinary management of gastrointestinal tumors. The program will focus on the latest data on prognostic and predictive markers that impact clinical decision-making, current and emerging treatment strategies, and case-based lectures by expert faculty whose will focus on the practical application of knowledge to the complex care scenarios encountered in contemporary practice settings.
This educational program is directed toward oncologists and gastroenterologists whose primary practice focus is GI cancers, and who intend to reinforce their knowledge base and expand their expertise in GI diagnosis, risk stratification, personalization of care, and best practices for multidisciplinary communication. Participants will be primarily oncologists, gastroenterologists, or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of GI cancers.
Program Co-ChairsJohn Marshall, MD
Chief, Division of Hematology/Oncology
Georgetown University Hospital
Director, Ruesch Center for the Cure of GI Cancers
Michael A Choti, MD, MBA, FACS
G Bayoud Professor of Surgical Oncology
UT Southwestern Medical Center
April 29, 2017
New York, NY
Cancer Summaries and Commentaries™: 2016 Conference Coverage: Advances in the Treatment of Genitourinary Cancers
Apr 29, 2017